- 4,5-MDAI
- 2-Amino-4,5-methylenedioxyindane
- 7,8-Dihydro-2H,6H-indeno[4,5-d][1,3]dioxol-7-amine
- 7,8-Dihydro-6H-indeno[4,5-d][1,3]dioxol-7-amine
Nichols, DE; Brewster, WK; Johnson, MP; Oberlender, R; Riggs, RM. Nonneurotoxic tetralin and indan analogues of 3,4-(methylenedioxy)amphetamine (MDA). J. Med. Chem., 1 Feb 1990, 33 (2), 703–710. 1.1 MB. https://doi.org/10.1021/jm00164a037 #4a NMR
Casale, JF; Hays, PA. Characterization of the “methylenedioxy-2-aminoindans”. Microgram J., 1 Jan 2011, 8 (2), 43–52. 1.3 MB. #2 GC,MS,NMR,IR
Nichols, DE; Oberlender, R. Structure-activity relationships of MDMA-like substances. In Pharmacology and Toxicology of Amphetamine and Related Designer Drugs. NIDA Research Monograph 94; Asghar, K; De Souza, E, Eds., U.S. Department of Health and Human Services, National Institute of Health, U.S. Government Printing Office, Washington, DC, 1 Jan 1989; pp 1-29. 282 kB.
Nichols, DF; Oberlender, R. Structure-activity relationships of MDMA and related compounds: A new class of psychoactive agents? In Ecstasy: The Clinical, Pharmacological and Neurotoxicological Effects of the Drug MDMA; Peroutka, SJ, Ed., Springer US, 1 Jan 1990; pp 105–131. 733 kB. https://doi.org/10.1007/978-1-4613-1485-1_7 #18
Oberlender, RA. Stereoselective aspects of hallucinogenic drug action and drug discrimination studies of entactogens. Ph. D. Thesis, Purdue University, West Lafayette, IN, 1 May 1989. 8.2 MB. #4,5-MDAI MS,NMR,IR,other